Fifth Third Bancorp’s Soleno Therapeutics SLNO Stock Holding History

Fifth Third Bancorp’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-331	Closed	-$11.1K	–	4439
2026 Q1	$11.1K	Buy	+331	New	+$13K	﹤0.01%	3674

Fifth Third Bancorp's SLNO Position: Q2 2026 in Review

Fifth Third Bancorp sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 331 shares — an estimated $11.1K sold.

Fifth Third Bancorp first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $11.1K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Fifth Third Bancorp reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Fifth Third Bancorp sold 331 Soleno Therapeutics shares in Q2 2026, an estimated $11.1K.
Fifth Third Bancorp first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Fifth Third Bancorp's Soleno Therapeutics position peaked at $11.1K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.